1. Home
  2. BCHT vs ALGS Comparison

BCHT vs ALGS Comparison

Compare BCHT & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Birchtech Corp. Common Stock

BCHT

Birchtech Corp. Common Stock

N/A

Current Price

$0.97

Market Cap

28.9M

Sector

Industrials

ML Signal

N/A

Logo Aligos Therapeutics Inc.

ALGS

Aligos Therapeutics Inc.

N/A

Current Price

$1.27

Market Cap

34.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BCHT
ALGS
Founded
N/A
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
28.9M
34.6M
IPO Year
2016
2020

Fundamental Metrics

Financial Performance
Metric
BCHT
ALGS
Price
$0.97
$1.27
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
★ $36.88
AVG Volume (30 Days)
57.5K
★ 69.7K
Earning Date
11-12-2026
11-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 88.30
EPS
★ N/A
N/A
Revenue
★ $17,626,366.00
$2,186,000.00
Revenue This Year
$4.39
$1,433.30
Revenue Next Year
$45.11
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 1.26
N/A
52 Week Low
$0.97
$1.22
52 Week High
$2.59
$13.69

Technical Indicators

Market Signals
Indicator
BCHT
ALGS
Relative Strength Index (RSI) 33.08 16.87
Support Level N/A N/A
Resistance Level $1.51 $7.79
Average True Range (ATR) 0.13 0.52
MACD -0.00 -0.26
Stochastic Oscillator 0.03 0.77

Price Performance

Historical Comparison
BCHT
ALGS

About BCHT Birchtech Corp. Common Stock

Birchtech Corp is a provider of specialty activated carbon technologies, delivering solutions for air and water purification. It provides patented and proprietary Sorbent Enhancement Additive (SEA) technologies for mercury emissions capture to the coal-fired utility sector, and is developing water purification technologies with a specialization on forever chemicals such as PFAS and PFOS. Geographically, the company derives all of its revenue from the United States.

About ALGS Aligos Therapeutics Inc.

Aligos Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics for liver diseases and viral infections. Its pipeline includes drug candidates targeting chronic hepatitis B virus (HBV) infection, metabolic dysfunction-associated steatohepatitis (MASH), obesity, and coronavirus infections, with programs such as pefivfoscorvir sodium for HBV, ALG-055009 for MASH and obesity, and ALG-097558 for coronavirus infections.

Share on Social Networks: